BBIO- Bridgebio Pharma, Inc.

Name: Bridgebio Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Viking Global Investors LP	18.56M	$1.28B	-
10%	Bridgebio Pharma LLC	14.59M	$1.01B	-
CEO	Kumar Neil	4.40M	$304.37M	-
Dir	Homcy Charles J	916.7K	$63.43M	-
Dir	McCormick Frank	766.6K	$53.05M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 29, 2021	Momtazee James C	Director	Buy	80,000	$14.50	$1,160,000.00	+942.2%	-23.5%	-46.7%
Dec 28, 2021	Daniels Ronald J	Director	Sell	11,745	$12.80	$150,336.00	-100%	-22.3%	-49.8%
Dec 28, 2021	Valantine Hannah53	Director	Buy	3,433	$12.96	$44,475.94	+181.5%	-22.3%	-49.8%
Aug 4, 2021	Scheller Richard H90	See Remarks	Sale+OE	13,777	$53.23	$733,316.65	-23.1%	-3.4%	-81.1%
Feb 17, 2021	Scott Randal W.45	Director	Buy	16,000	$62.50	$1,000,000.00	+320.0%	-13.9%	-87.1%
Feb 17, 2021	Stephenson Brian C	See Remarks	Buy	8,000	$62.50	$500,000.00	+2.7%	-13.9%	-87.1%
Jan 26, 2021	Bridgebio Pharma, Inc.	10% Owner	Buy	14,428,836	$0.00	-	-100.0%	-	-
Dec 28, 2020	Turtle Cameron	See Remarks	Sale+OE	19,500	$69.60	$1,357,184.04	-36.7%	-	-
Dec 21, 2020	Scheller Richard H90	See Remarks	Sell	60,401	$65.32	$3,945,136.77	-30.6%	-	-
Dec 18, 2020	Scheller Richard H90	See Remarks	Sell	30,000	$65.07	$1,952,020.84	-12.2%	-	-

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC